Evidence map›Paper›PMID 41648849›Full record

ArticleFrontiers in digital health2026

Predictive fetal medicine and the ownership of prenatal data: legal, ethical, and professional challenges.

Yoann Marechal

Abstract read
In one paragraph

Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yoann MarechalPediatric and Neonatal Intensive Care, Hôpital Civil de Charleroi, Charleroi, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in artificial intelligence and multi-omic analysis are transforming fetal medicine from a diagnostic discipline into a predictive one. Yet the legal, deontological, and ethical frameworks that govern prenatal and fetal data have not evolved accordingly. Current regulations protect the mother as a patient but do not recognize the fetus-or the future child-as a legal data subject. As a result, information generated before birth remains confined within maternal medical records, creating uncertainty about who may later access or reuse it. This paper examines the emerging ethical and legal challenges of predictive fetal medicine, focusing on the transition from maternal consent to the child's future right to their own prenatal data. Through the lens of professional deontology and comparative law, we analyze the tensions between confidentiality, autonomy, and beneficence. We propose a framework of prenatal data stewardship, shifting from static notions of data ownership to shared responsibility across time. Establishing national or international repositories under transparent governance could enable ethical reuse of fetal data while safeguarding maternal privacy and ensuring future individuals' rights. Ultimately, aligning predictive fetal medicine with ethical and legal coherence requires collective action among clinicians, ethicists, jurists, policymakers, and industry. Only through such stewardship can information generated before birth become a trusted tool for care rather than control.

Indexed as

antenatal exposurefetal dataownership (not absolute)predictive medicineprofessional secret

Identifiers

PMID41648849
PMCPMC12868176

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.